Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Neuroendocrine Tumors × Positron Emission Tomography Computed Tomography × Clear all

Phase

Phase 2 2 Phase 1 2 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Leukemia, T-Cell 1 Leukemia 1 Disease 1 Colonic Neoplasms 1

Interventions

Al18F-NOTA-octreotide 2 lutetium Lu 177 dotatate 1 Somatostatin 1 Positron Emission Tomography Computed Tomography 1 Oxaliplatin 1 Leucovorin 1 Fluorouracil 1 Everolimus 1 Bevacizumab 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04552847 2022-02-17

Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors

Universitaire Ziekenhuizen KU Leuven

Phase 2/3 Completed

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡